Frontlight ResearchEarly access
Trial site
251 Air Force General Hospital
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma4 trials
- Lung cancer2 trials
- Atopic dermatitis (eczema)1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- and 1 more
- Phase
- Phase 39 trials
- Phase 23 trials
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Amgen2 trials
- Incyte Corporation2 trials
- Janssen Research & Development, LLC2 trials
- AbbVie1 trial
- CareAcross1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma2 recruiting
- Heart failure1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Obesity1 recruiting
- Sarcoma1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Site data: ClinicalTrials.govUpdated 14 Nov 2026